Published in Cancer J on December 13, 2011
Identification of Lynch syndrome among patients with colorectal cancer. JAMA (2012) 2.77
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol (2014) 1.03
History, genetics, and strategies for cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol (2013) 0.95
The molecular genetics of colorectal cancer. Frontline Gastroenterol (2013) 0.90
Biology of colorectal cancer. Ecancermedicalscience (2015) 0.90
Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology (2013) 0.86
Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer. Cancer Lett (2012) 0.85
Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update. Eur J Gastroenterol Hepatol (2014) 0.83
APC rearrangements in familial adenomatous polyposis: heterogeneity of deletion lengths and breakpoint sequences underlies similar phenotypes. Fam Cancer (2015) 0.82
Racial and Ethnic Disparities in Colonoscopic Examination of Individuals With a Family History of Colorectal Cancer. Clin Gastroenterol Hepatol (2015) 0.80
Two Chinese pedigrees for adenomatous polyposis coli: new mutations at codon 1309 and predisposition to phenotypic variations. Fam Cancer (2014) 0.78
Epidural brain metastases in a patient with early onset pancreatic cancer: a case report and literature review. Case Rep Oncol Med (2012) 0.76
Rheumatoid Arthritis as a Therapeutic Challenge in a Patient with Lynch Syndrome. Am J Case Rep (2015) 0.75
Pancreaticoduodenectomy for locally advanced colon cancer in hereditary nonpolyposis colorectal cancer. World J Surg Oncol (2016) 0.75
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. Mol Genet Genomic Med (2017) 0.75
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Hereditary colorectal cancer. N Engl J Med (2003) 11.86
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41
Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet (2002) 7.00
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med (2006) 5.70
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol (2003) 5.69
Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol (2008) 5.47
Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology (2008) 5.19
Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med (2006) 4.95
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med (2003) 4.88
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA (2006) 4.87
Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA (2006) 4.34
Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet (1999) 4.16
Hereditary and familial colon cancer. Gastroenterology (2010) 4.15
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA (2005) 3.99
Familial adenomatous polyposis. Am J Gastroenterol (2006) 3.77
Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol (2006) 3.02
Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med (1966) 2.86
Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) (2010) 2.86
Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer (1995) 2.85
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology (2009) 2.75
Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer (2004) 2.53
Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Hum Mol Genet (2002) 2.48
Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology (2009) 2.42
Duodenal adenomatosis in familial adenomatous polyposis. Gut (2004) 2.38
MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology (2004) 2.35
Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology (2006) 2.34
High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol (2010) 2.32
Risk of pancreatic cancer in families with Lynch syndrome. JAMA (2009) 2.32
Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr (2008) 2.29
Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet (1999) 2.27
NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13
Colon cancer screening. Gastroenterology (2000) 2.01
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol (2010) 1.98
Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology (1991) 1.97
Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology (2010) 1.96
Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer (2003) 1.93
Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut (1997) 1.88
The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology (2010) 1.88
The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med (2003) 1.84
Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet (1996) 1.76
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med (1987) 1.76
Genetic testing for high-risk colon cancer patients. Gastroenterology (2003) 1.72
DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet (1996) 1.64
Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet (1997) 1.63
Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol (2001) 1.58
Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet (2001) 1.51
MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer (2006) 1.46
Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev (2006) 1.46
Prediction of Lynch syndrome in consecutive patients with colorectal cancer. J Natl Cancer Inst (2009) 1.40
Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol (2009) 1.39
Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis (1996) 1.24
Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology (2004) 1.22
Adenomatous polyposis families that screen APC mutation-negative by conventional methods are genetically heterogeneous. J Clin Oncol (2005) 1.14
Colonic polyposis and neoplasia in Cowden syndrome. Mayo Clin Proc (2011) 1.14
Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet (2006) 1.13
Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer. Int J Cancer (2010) 1.12
Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer (2006) 1.11
APC mutations in familial adenomatous polyposis families in the Northwest of England. Hum Mutat (1997) 1.10
A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers. Ann Oncol (2009) 1.05
Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients. Int J Cancer (2006) 1.02
Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol (2000) 1.00
Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol (2007) 0.99
Recently identified colon cancer predispositions: MYH and MSH6 mutations. Semin Oncol (2007) 0.94
Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol (2005) 0.84
Inherited polyposis syndromes: molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol (2005) 0.79
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov (2011) 3.27
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol (2014) 3.07
Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA (2004) 2.99
Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) (2010) 2.86
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology (2009) 2.75
Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA (2006) 2.73
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res (2002) 2.33
Risk of pancreatic cancer in families with Lynch syndrome. JAMA (2009) 2.32
Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut (2012) 2.17
Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev (2006) 2.04
Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology (2008) 2.01
Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol (2012) 1.99
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol (2010) 1.98
The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology (2010) 1.88
Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol (2004) 1.76
Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med (2011) 1.70
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65
Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J Mol Diagn (2004) 1.62
Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol (2009) 1.62
Knowledge of quality performance measures associated with endoscopy among gastroenterology trainees and the impact of a web-based intervention. Gastrointest Endosc (2012) 1.59
Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol (2008) 1.55
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol (2005) 1.50
Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) (2008) 1.47
Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology (2010) 1.46
Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA (2008) 1.46
The comprehensiveness of family cancer history assessments in primary care. Community Genet (2007) 1.42
Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis. J Natl Cancer Inst (2004) 1.42
Hereditary colorectal cancer syndromes. Cancer Causes Control (2005) 1.40
Factors associated with enrollment in cancer genetics research. Cancer Epidemiol Biomarkers Prev (2006) 1.31
Hereditary pancreatic cancer. Gastroenterology (2010) 1.31
Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med (2004) 1.30
Timing of colonoscopy: impact on length of hospital stay in patients with acute lower intestinal bleeding. Am J Gastroenterol (2003) 1.28
Colorectal cancers with microsatellite instability display unique miRNA profiles. Clin Cancer Res (2011) 1.27
F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA (2008) 1.26
Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol (2008) 1.20
Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med (2003) 1.19
Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States. Cancer Epidemiol Biomarkers Prev (2008) 1.16
Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology (2007) 1.16
Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol (2013) 1.14
Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res (2009) 1.14
Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diagn (2004) 1.11
Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) (2008) 1.11
Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol (2003) 1.10
Colorectal cancer in young adults. Dig Dis Sci (2014) 1.08
Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology (2006) 1.08
Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat (2011) 1.07
Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med (2011) 1.05
Validation of a clinical prediction rule for severe acute lower intestinal bleeding. Am J Gastroenterol (2005) 1.04
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol (2010) 1.03
The impact of family history of diabetes on glucose testing and counseling behavior in primary care. Diabetes Care (2004) 1.02
Genetic testing in gastroenterology: Lynch syndrome. Best Pract Res Clin Gastroenterol (2009) 1.02
Colon cancer screening strategies. Curr Opin Gastroenterol (2005) 0.98
Predictors of utilization of early colonoscopy vs. radiography for severe lower intestinal bleeding. Gastrointest Endosc (2005) 0.98
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol (2015) 0.96
Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol (2009) 0.96
Colorectal cancer screening: prevalence among low-income groups with health insurance. Health Aff (Millwood) (2009) 0.96
Recently identified colon cancer predispositions: MYH and MSH6 mutations. Semin Oncol (2007) 0.94
Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol (2012) 0.94
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc (2014) 0.94
Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome. Am J Surg Pathol (2009) 0.94
Risk assessment, genetic testing, and management of Lynch syndrome. J Natl Compr Canc Netw (2010) 0.92
Screening patients with colorectal cancer for Lynch syndrome: what are we waiting for? J Clin Oncol (2012) 0.92
Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol (2007) 0.90
Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med (2012) 0.87
Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology (2013) 0.86
Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology (2004) 0.86
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum (2014) 0.85
Identification of germline genomic copy number variation in familial pancreatic cancer. Hum Genet (2012) 0.85
Colorectal cancer screening awareness and intentions among low income, sociodemographically diverse adults under age 50. Cancer Causes Control (2008) 0.85
Prediction models in Lynch syndrome. Fam Cancer (2013) 0.84
Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol (2005) 0.84
Data reduction for prediction: a case study on robust coding of age and family history for the risk of having a genetic mutation. Stat Med (2007) 0.83
Adenomas in young patients: what is the optimal evaluation? Am J Gastroenterol (2005) 0.81
Linkage analysis of chromosome 4 in families with familial pancreatic cancer. Cancer Biol Ther (2007) 0.80
Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome. Surg Endosc (2014) 0.80
Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification? Am J Gastroenterol (2008) 0.80
Multivitamin use among multi-ethnic, low-income adults. Cancer Causes Control (2009) 0.79
An American founder mutation in MLH1. Int J Cancer (2011) 0.79
Dysplasia in Barrett esophagus. Cancer (2004) 0.78
One less thing to worry about: the shrinking spectrum of tumors in BRCA founder mutation carriers. J Natl Cancer Inst (2004) 0.78
Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome. Fam Cancer (2011) 0.77
Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA Dermatol (2014) 0.76
Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Int J Gynecol Pathol (2017) 0.76
Gastropericardial fistula-induced pericarditis: an unusual consequence of GERD. Medscape J Med (2008) 0.75
Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test. Cancer Biomark (2011) 0.75
Changes in colorectal cancer screening intention among people aged 18-49 in the United States. BMC Public Health (2014) 0.75
Genetic testing for hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol (2003) 0.75
Colon cancer screening strategies. Curr Opin Gastroenterol (2002) 0.75
Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors. Surgery (2004) 0.75